Defining 3D characteristics of high-risk pancreatic precancer lesions for interception

Closing date: 15/11/2024

Clinical Research Training Fellowship Project: Defining 3D characteristics of high-risk pancreatic precancer lesions for interception

Lead Supervisors: Prof. Claus Jorgensen
Co-Supervisors: 
Prof. David Wedge, Dr Emma Woodward, Dr Lucy Foster

Applications Deadline: Friday 15th November 2024
Interviews: Friday 17th January 2025
Clinical Research Training Fellowship start date: September 2025

Project Keywords: Early cancer evolution, Pancreatic Cancer, Tumour Microenvironment
Research Opportunity: Clinical Research Training Fellowship leading to the award of PhD

Project Outline

Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease with poor overall survival. Most patients are still identified too late to benefit from surgery and are only given chemotherapy. This is mainly because early disease is mostly asymptomatic and escapes detection. Therefore, improved early detection and intervention requires detailed understanding of the pre-cancerous stages, how progress is controlled and associated mechanisms.

To address this, we will interrogate early stages of pancreatic cancer using a combination of genomics, transcriptomics and imaging to reveal markers associated with malignant progression. What’s unique about this project is that we will do this analysis in 3D rather than in 2D to reveal structural and cellular changes of early cancer stages which then will guide rational molecular interrogation.

This project is highly interdisciplinary with experts in PDAC biology and the microenvironment, cancer genomics and computational analysis, clinical geneticists and pathologists. 

Applications for this project are now open. Please complete your application on The University of Manchester website.

About Prof. Claus Jorgensen (project Lead Supervisor)

Claus Jorgensen is a senior group leader at the CRUK Manchester Institute with an established track record in functional annotation of the tumour microenvironment in pancreatic cancer. The lab focus on determining how the microenvironment regulate pancreatic cancer progression and in turn how this presents targetable vulnerabilities. The lab has significant expertise in spatial, sequencing and proteomics analysis, as well as in development of new model systems (Hutton et al Cancer Cell 2021, Tape et al Cell 2016, Below et al Nat Material 2022).

Prof. Claus Jorgensen headshot

Key information

Before submitting an application, please ensure you have read the information below about the funding arrangements and eligibility for the Leeds-Manchester Clinical Research Training Fellowships.

We also encourage you to get in contact with the lead supervisor to discuss the project and any particulars.

Further information is available on the Clinical Research Training Fellowships webpage.

Fees and Funding
Eligibility
Applications Timelines

Useful Links

Submit your application

Interested in applying for this opportunity? Go to The University of Manchester website to submit your application.

Clinical Research Training Fellowships

Discover our various opportunities for clinicians looking to undertake a period of PhD training in a cancer-relevant field.

Get in Touch

Contact Dr Georgina Binnie-Wright, Postgraduate Programme Manager.

Researcher Stories

Read first-hand experiences of from cancer scientists from across Manchester.

Why Manchester?

Find out why postgraduate students choose to study in Manchester.

A Day in the Life of a Clinical PhD Student

Watch our short video to see what it's like to be a Clinical Research Training Fellow in Manchester.